Dose, Safety and Pathogenicity of SARS-CoV-2 (COVID-19) Omicron Virus (BA.5)

Clinical trial NCT06492564 · COMPLETED

Trial details

NCT number: NCT06492564
Sponsor: Hvivo
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2024-12-02
Primary completion: 2025-10-16
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.